Novel terpolymer formulation combining bio-based hydrophobic monomers (myrcene, farnesene, alkyl methacrylates) with adhesion-promoting comonomers and cyclic ketene acetals (CKAs) to create degradable moisture barrier skin layers for food packaging films. Designed for co-extrusion and blending with PLA.
This research proposes a new class of multi-functional moisture barrier materials based on terpolymers that combine bio-based hydrophobic comonomers with adhesion-promoting functional monomers and cyclic ketene acetals (CKAs). The resulting polymers are designed to serve as skin layers in co-extruded or blended food packaging films, offering both moisture resistance and controlled degradability. By integrating hydrophobic bio-derived monomers such as myrcene, farnesene, or alkyl methacrylates with functional monomers like glycidyl methacrylate and hydrolyzable CKAs, these terpolymers address the dual challenges of barrier performance and end-of-life sustainability in packaging applications.
Key material design features:
Research approach:
This research is at an early stage (TRL 1-2). The hypothesis has not yet been experimentally validated. The research team has prior experience with bio-based dienes and vegetable oil-based methacrylates for thermoplastic elastomers and has demonstrated copolymerization of dienes with polar monomers. However, the specific combination of these monomers with CKAs for moisture barrier applications requires systematic validation. Key next steps include confirming moisture barrier properties, optimizing monomer ratios, demonstrating terpolymerization with CKAs, and conducting blending and adhesion studies with PLA. Access to moisture testing equipment is identified as a critical need for advancing this research.
McGill University is a comprehensive public research university in Montréal, Québec, known for an international community and a research‑intensive culture. Faculty and industry collaborate through shared core facilities and co‑located labs across downtown and hospital sites, with integration into a major hospital system enabling clinical research and translation. Proximity to Montréal’s established industry clusters and a vibrant innovation district give companies access to talent, pilots, and testbeds. Research is supported by Canada’s Tri‑Agency and the Canada Foundation for Innovation, alongside provincial and philanthropic sources. A dedicated technology transfer office streamlines contracting and IP, supports licensing and sponsored research, and connects partners to startups and entrepreneurship resources.